Cero Therapeutics Holdings, Inc. SC 13G and SC 13G/A reports

Location
201 Haskins Way, Suite 230, South San Francisco, California
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
5/17/2024, 05:11 PM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report Feb 22, 2024
SC 13G/A Report FORM SC 13G/A Feb 8, 2024
SC 13G/A Report Feb 14, 2023
SC 13G/A Report Feb 14, 2023
SC 13G/A Report FORM SC 13G/A Feb 14, 2023
SC 13G Report Feb 14, 2023
SC 13G/A Report Feb 13, 2023
SC 13G/A Report PHOENIX BIOTECH ACQUISITION CORP. Jan 25, 2023
SC 13G Report FORM SC 13G May 6, 2022
SC 13G/A Report AMENDMENT NO. 1 TO SCHEDULE 13G Feb 14, 2022
SC 13G/A Report Feb 11, 2022
SC 13G Report SC 13G Feb 8, 2022
SC 13G/A Report PHOENIX BIOTECH ACQUISITION CORP. Feb 3, 2022
SC 13G Report PHOENIX BIOTECH ACQUISITION CORP. Oct 22, 2021
SC 13G Report Oct 18, 2021
SC 13G Report SCHEDULE 13G Oct 18, 2021